Lipocine  logo
Lipocine LPCN
€ 1.34 -3.29%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 05.11.2026

Lipocine Betriebsaufwand | LPCN

Betriebsaufwand Jährlich Lipocine

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
12.3 M 12.4 M 15.1 M 12.6 M 13 M 8.25 M 5.6 M 5.29 M 21.2 M 19.2 M 5.8 M 5 M 10.7 M 3.83 M -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
21.2 M 3.83 M 10.7 M

Betriebsaufwand Vierteljährlich Lipocine

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
3.16 M 3.03 M 3.97 M 3.66 M 3.48 M 3.03 M 2.18 M 1.95 M 2.63 M 3.38 M 4.39 M 2.81 M 3.92 M 3.96 M 4.39 M 2.56 M 2.9 M 4.03 M 3.13 M 3.3 M 3.59 M 2.99 M 3.11 M 4.8 M 4.38 M 4.22 M 4.6 M 3.45 M 3.14 M 3.35 M 3.13 M 3.17 M 2.35 M 3.16 M 3.07 M 5.4 M 4.77 M 6.14 M 4.91 M 3.02 M 3.29 M 5.82 M 7.07 M 4.7 M 6.43 M 4.28 M 2.97 M - 4.12 M 7.01 M 5.29 M 4.41 M 3.55 M 1.37 M 1.35 M 879 K 1.02 M - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
7.07 M 879 K 3.68 M

Betriebsaufwand anderer Aktien in der Pharmaeinzelhändler

Name Betriebsaufwand Preis % 24h Marktkapitalisierung Land
Seres Therapeutics Seres Therapeutics
MCRB
94.8 M $ 1.25 -6.02 % $ 11.1 M usaUSA
Oramed Pharmaceuticals Oramed Pharmaceuticals
ORMP
15.1 M $ 3.58 -2.98 % $ 148 M israelIsrael
Madrigal Pharmaceuticals Madrigal Pharmaceuticals
MDGL
1.26 B $ 378.19 -4.68 % $ 8.48 B usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
24.8 M $ 1.2 -18.37 % $ 9.62 M usaUSA
Inventiva S.A. Inventiva S.A.
IVA
36.2 M $ 3.14 -9.13 % $ 188 M franceFrance
MeiraGTx Holdings plc MeiraGTx Holdings plc
MGTX
187 M $ 7.98 -1.97 % $ 642 M usaUSA
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited
TEVA
6.78 B $ 39.21 1.76 % $ 44.9 B israelIsrael
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
43.6 M $ 60.77 -0.96 % $ 1.64 B usaUSA
IDEAYA Biosciences IDEAYA Biosciences
IDYA
378 M $ 25.52 -2.48 % $ 2.26 B usaUSA
Protalix BioTherapeutics Protalix BioTherapeutics
PLX
31.3 M $ 2.89 -5.56 % $ 227 M israelIsrael
Lantern Pharma Lantern Pharma
LTRN
18 M $ 0.25 -13.67 % $ 2.72 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
117 M $ 1.71 -3.93 % $ 108 M usaUSA
Ocugen Ocugen
OCGN
67.3 M $ 0.77 4.74 % $ 241 M usaUSA
Oncolytics Biotech Oncolytics Biotech
ONCY
11.5 M $ 0.35 -10.37 % $ 33.6 M canadaCanada
Minerva Neurosciences Minerva Neurosciences
NERV
15.1 M $ 2.03 -4.25 % $ 17.2 M usaUSA
Neurocrine Biosciences Neurocrine Biosciences
NBIX
2.19 B $ 150.5 -3.89 % $ 15 B usaUSA
Nanobiotix S.A. Nanobiotix S.A.
NBTX
43.4 M $ 26.12 -1.7 % $ 1.25 T franceFrance
Prothena Corporation plc Prothena Corporation plc
PRTA
224 M $ 8.12 -3.33 % $ 437 M usaUSA
Mereo BioPharma Group plc Mereo BioPharma Group plc
MREO
39.5 M $ 0.26 -5.45 % $ 207 M britainBritain
Maravai LifeSciences Holdings Maravai LifeSciences Holdings
MRVI
249 M $ 6.99 -2.85 % $ 1.01 B usaUSA
Lexicon Pharmaceuticals Lexicon Pharmaceuticals
LXRX
98.4 M $ 1.53 -8.68 % $ 555 M usaUSA
Moleculin Biotech Moleculin Biotech
MBRX
25.1 M $ 7.73 -2.59 % $ 9.16 M usaUSA
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
TAK
2.66 T $ 21.79 1.66 % $ 34.4 B japanJapan
Nurix Therapeutics Nurix Therapeutics
NRIX
370 M $ 12.88 -5.29 % $ 1.12 B usaUSA
Nkarta Nkarta
NKTX
122 M $ 1.14 1.34 % $ 84.3 M usaUSA
MacroGenics MacroGenics
MGNX
72.8 M $ 1.97 -0.76 % $ 124 M usaUSA
Protagonist Therapeutics Protagonist Therapeutics
PTGX
204 M $ 121.72 -2.2 % $ 7.74 B usaUSA
Novo Nordisk A/S Novo Nordisk A/S
NVO
123 B $ 37.8 -2.82 % $ 168 B danmarkDanmark
Marker Therapeutics Marker Therapeutics
MRKR
16.4 M $ 1.1 -17.05 % $ 16.8 M usaUSA
Arcus Biosciences Arcus Biosciences
RCUS
633 M $ 15.62 -1.01 % $ 1.68 B usaUSA
Replimune Group Replimune Group
REPL
320 M $ 19.07 -0.83 % $ 1.77 B usaUSA
NextCure NextCure
NXTC
15.1 M $ 6.62 -2.43 % $ 35.2 M usaUSA
Rocket Pharmaceuticals Rocket Pharmaceuticals
RCKT
232 M $ 1.95 -7.82 % $ 217 M usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
86.2 M $ 0.87 -33.79 % $ 45.7 M usaUSA
United Therapeutics Corporation United Therapeutics Corporation
UTHR
1.31 B $ 553.08 -1.08 % $ 24.5 B usaUSA
Olema Pharmaceuticals Olema Pharmaceuticals
OLMA
179 M $ 7.0 -2.1 % $ 609 M usaUSA
Kymera Therapeutics Kymera Therapeutics
KYMR
389 M $ 115.19 -3.52 % $ 9.73 B usaUSA
Oragenics Oragenics
OGEN
9.36 M $ 0.16 -6.16 % $ 345 K usaUSA
Ovid Therapeutics Ovid Therapeutics
OVID
49.7 M $ 2.2 -5.98 % $ 286 M usaUSA
Passage Bio Passage Bio
PASG
8.27 M $ 3.94 9.14 % $ 12.6 M usaUSA
Vaxcyte Vaxcyte
PCVX
924 M $ 55.37 -5.12 % $ 7.54 B usaUSA
Relay Therapeutics Relay Therapeutics
RLAY
318 M $ 16.11 1.26 % $ 2.76 B usaUSA
Precigen Precigen
PGEN
120 M $ 4.21 1.08 % $ 1.32 B usaUSA
Avidity Biosciences Avidity Biosciences
RNA
765 M $ 6.94 -0.57 % $ 956 M usaUSA
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp.
PHIO
9.22 M $ 0.66 -7.55 % $ 3.95 M usaUSA
Praxis Precision Medicines Praxis Precision Medicines
PRAX
326 M $ 300.01 -3.5 % $ 6.75 B usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
117 M $ 3.22 -1.08 % $ 248 M usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
59.8 M $ 1.02 -2.38 % $ 107 M niderlandNiderland
Ocular Therapeutix Ocular Therapeutix
OCUL
315 M $ 5.57 -5.03 % $ 1.04 B usaUSA